Valvular Assessment of New Generation Aortic Replacement Devices — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Valvular Assessment of New Generation Aortic Replacement Devices — Stella

Home/Aortic Regurgitation Disease/

View on ClinicalTrials.gov

Recruiting

Back to Aortic Regurgitation Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Brazil

Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo

Key details

Sponsor

Instituto Dante Pazzanese de Cardiologia

Enrollment target

~200 participants

Started

December 2024

Primary completion

December 2026

Age range

18 Years – 65 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.